Latest SENS Announcements for Aspen Pharmacare Hldgs Ltd

View All SensBack To Issuer
Availability of Integrated Report, B-BBEE Verification Certificate and further Notice of Annual General Meeting
d66fc299-6564-4561-bb28-a57feb4a7de8
S496379 -
Download
Granting of Securities to Directors, Prescribed Officers and the Company Secretary of the Company
4691d78a-0ac6-4619-86ab-1c0feb8fff55
S495818 -
Download
Dealing in Securities by Directors, Prescribed Officers and the Company Secretary
8546d117-2dce-4215-b9cb-ae3b64642364
S495590 -
Download
No Change Statement, availability of Audited Annual Financial Statements and Notice of Annual General Meeting
443fdce4-ab61-4443-b392-0a5acf098277
S495382 -
Download
Dealing in Securities by Director of the Company
c19d23e0-bfed-44c9-9cbb-093f2dceb544
S494894 -
Download
Condensed Group Financial Results for the Year Ended 30 June 2024 and Cash Dividend Declaration
05de7ce8-531b-4555-8bae-bb344954803a
S494132 -
Download
Reminder of release of Annual Financial Results for the Year Ended 30 June 2024 and a Live Presentation thereof
f3a13738-bfb0-4449-bf6d-17f8373e6666
S493358 -
Download
Correction Announcement: Notice of Availability of Results Presentation
b90ed80c-4d95-45e9-9ca7-bea602ad5002
S491813 -
Download
Notice regarding the release of Aspen’s Financial Results for the year ending 30 June 2024, and Results Presentation
258d38b1-fcaa-4e09-b343-605e8be25c4d
S491769 -
Download
Dealing in Securities by a Director and Prescribed Officer
4e2c7a78-c189-43e6-9d06-b98d0befe306
S489996 -
Download
Completion of two Transactions with Sandoz
44a6f6d3-7631-40da-af2f-6ed2167fd54f
S487821 -
Download
Appointment of Directors
8cfe0a97-84df-424a-b184-23dc36b24e62
S486659 -
Download
Unaudited Interim Group Financial Results for the six months ended 31 December 2023
86c16323-66fe-4b5d-9864-a754ef848284
S486400 -
Download
Reminder of the Release of Interim Results for the six months ended 31 December 2023 and a Live Presentation Thereof
e9086246-3398-433c-8ce1-a4e428b497b0
S486074 -
Download
Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements
5d5b7af6-20b3-4b97-859d-f44854041dd0
S485277 -
Download
Aspen’s Results for the six months ended 31st December 2023 and Results Presentation
cabbcfc8-bf0c-475f-ab20-dd792fdbfa8e
S485101 -
Download
Appointment of Group Company Secretary
e8fcd133-64f9-4352-8183-37c89642e21b
S483506 -
Download
Report on Annual General Meeting Proceedings
7d9c33a7-b14f-4574-a44d-b29c6f519ff4
S483438 -
Download
Completion of the Acquisition of Distribution and Promotion Rights from Lilly
ce8ce8df-9952-470b-8df2-19e67edd3ef8
S483412 -
Download
Aspen reaches Agreement on two transactions with Sandoz
768b234f-46f4-4f2e-80b5-0f4247807c1e
S483232 -
Download